No Job fitting your profile right now ? this link is for you ! Feel free to send us your application!

The Human Biomonitoring Research Unit (HBRU) is specialized in the assessment of human exposure to pollutants and on the study of exposure-associated health outcomes. Research activities rely on both animal experimentation and human volunteers within epidemiological studies. The laboratory is equipped with up-to-date analytical equipment mainly consisting in CG-MS/MS and UHPLC-MS/MS).

To be part of the NORLUX Neuro-Oncology Laboratory (Group leaders: Prof Simone Niclou and Dr. Anna Golebiewska within the Department of Oncology at the LIH, we are currently looking for a Postdoctoral Fellow.

To be part of the NORLUX Neuro-Oncology laboratory (Group leaders: Prof Simone Niclou and Dr. Anna Golebiewska) within the Department of Oncology at the LIH, we are currently looking for a Postdoctoral Fellow.

Researchers from the NORLUX Neuro-Oncology Laboratory at the LIH Department of Oncology (DONC) explored the molecular mechanisms responsible for the ability of Glioblastoma (GBM) to infiltrate and spread to healthy brain tissue. They brought forward the novel role of protein ZFAND3 in promoting the transcription of several genes that stimulate the invasion of GBM cells in the surrounding parenchyma, the functional tissue in the brain. The findings, which carry significant implications for the development of novel therapeutic strategies against GBM, were published in the international journal Nature Communications.

On December 9th, Medical & Bio Decision (MBD) announced the setup of a joint laboratory for precision medicine tailored to cancer patients, in collaboration with the Luxembourg Institute of Health (LIH) and the Integrated Biobank of Luxembourg (IBBL).

Dr Andy Chevigné and Dr Martyna Szpakowska from the LIH Department of Infection and Immunity (DII) were rewarded for their outstanding contribution to molecular pharmacology during a virtual ceremony on Tuesday, December 8th, in the presence of Frank Vandenbroucke, Belgian Minister of Public Health and Social Affairs, and of representatives of pharmaceutical companies and healthcare hubs. The Galien Prize is traditionally organised in Belgium and Luxembourg by Roularta HealthCare on a yearly basis and crowns the most significant discoveries in the fields of pharmacology, drug development and medical devices.

WEBINAR: Lecture series Cancer Research: "Die or live trying - Cellular agony in anticancer immunity" - Prof Lorenzo Galluzzi

i2TRON is a highly innovative PhD training program on “integrating immune strategies for Translational Research in Oncology and Neurology” and is supported by the Luxembourg National Research Fund (FNR) within their PRIDE program. We will develop the next generation of translational scientists as boundary crossers, domain experts and skilled communicators. Inflammation is a common hallmark shared across different non-communicable diseases (NCD).